Long

FPRX was a top gainer,rising +132.36%.Expect an Uptrend reversal

Five Prime Therapeutics (FPRX, $6.39) was one of top quarterly gainers, jumping +132.36% to $6.39 per share. Tickeron A.I.dvisor analyzed 380 stocks in the Biotechnology Industry over the last three months, and discovered that 356 of them (93.72%) charted an Uptrend while 24 of them (6.28%) trended down. Tickeron A.I.dvisor found 279 similar cases when FPRX's price went up 15% within three months. In 201 out of those 279 cases, FPRX's price went down during the following month. Based on these historical data, Tickeron A.I. thinks the odds of an Uptrend reversal for FPRX are 72%.
biotechnologyTrend Analysis

Declinazione di responsabilità